NasdaqGS - Delayed Quote • USD
Viatris Inc. (VTRS)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:44 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 7 | 8 |
| Avg. Estimate | 0.67 | 0.69 | 2.78 | 2.79 |
| Low Estimate | 0.64 | 0.66 | 2.71 | 2.7 |
| High Estimate | 0.7 | 0.72 | 2.84 | 2.92 |
| Year Ago EPS | 0.77 | 0.75 | 2.93 | 2.78 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 7 |
| Avg. Estimate | 3.7B | 3.83B | 15.38B | 15.07B |
| Low Estimate | 3.53B | 3.65B | 14.82B | 14.24B |
| High Estimate | 3.82B | 3.9B | 15.54B | 15.81B |
| Year Ago Sales | 3.73B | -- | 15.43B | 15.38B |
| Sales Growth (year/est) | -0.90% | -- | -0.30% | -2.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.69 | 0.71 | 0.74 | 0.65 |
| EPS Actual | 0.77 | 0.75 | 0.79 | 0.62 |
| Difference | 0.08 | 0.04 | 0.05 | -0.03 |
| Surprise % | 11.60% | 5.60% | 6.80% | -4.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.67 | 0.69 | 2.78 | 2.79 |
| 7 Days Ago | 0.68 | 0.69 | 2.78 | 2.79 |
| 30 Days Ago | 0.69 | 0.69 | 2.78 | 2.79 |
| 60 Days Ago | 0.74 | 0.72 | 2.81 | 2.88 |
| 90 Days Ago | 0.74 | 0.72 | 2.8 | 2.9 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| CURRENCY IN USD | VTRS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -13.00% | -- | -- | 5.40% |
| Next Qtr. | -8.00% | -- | -- | 10.90% |
| Current Year | -5.10% | -- | -- | 4.50% |
| Next Year | 0.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -2.25% | -- | -- | 10.94% |
| Past 5 Years (per annum) | -10.00% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Piper Sandler: Neutral to Neutral | 3/28/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 11/22/2023 |
| Downgrade | B of A Securities: Neutral to Underperform | 10/23/2023 |
| Downgrade | Barclays: Equal-Weight to Underweight | 6/23/2023 |
| Downgrade | Barclays: Overweight to Equal-Weight | 4/25/2023 |
| Downgrade | Barclays: Overweight to Equal-Weight | 4/24/2023 |
Related Tickers
TEVA Teva Pharmaceutical Industries Limited
13.81
+4.23%
ELAN Elanco Animal Health Incorporated
13.26
+1.69%
HLN Haleon plc
8.45
+0.60%
ZTS Zoetis Inc.
158.42
+3.30%
TAK Takeda Pharmaceutical Company Limited
13.03
-0.31%
BHC Bausch Health Companies Inc.
8.71
+1.04%
ESPR Esperion Therapeutics, Inc.
1.9000
-4.52%
DVAX Dynavax Technologies Corporation
11.21
+0.36%
EOLS Evolus, Inc.
11.43
-0.26%
DCPH Deciphera Pharmaceuticals, Inc.
14.65
+3.31%